Xcout Intel
Automera
Automera is an early-stage biotechnology research company headquartered in Singapore. The company focuses on the development of novel therapeutics through autophagy-based targeted protein degradation.
Subscribe to see Automera’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Automera at a glance
Automera is a drug discovery company headquartered in Singapore. Its most recent funding round, Series A, raised $16M in September 2023. Xcout tracks 7 named people at Automera, including Thong Q. Le (Chief Executive Officer).
Automera leadership
- Thong Q. LeChief Executive Officer
- Shawn HoonChief Scientific Officer
- Loong WangChief Technology Officer & Co-Founder
- Michael LazarouCo-Founder
- Pearly NgHead of Chemistry
- Alice ChenExecutive Vice President
1 more named person on record for Automera, with roles, board committees and tenure — see the full roster →
Automera funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $16M | 5 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Automera competitors
A few of Automera's closest competitors — see the full list of competitors and alternatives →
Gero is a biotechnology company headquartered in Singapore with a U.S. subsidiary, combining physics, biology, and artificial intelligence to decode human biology and develop life-changing medicines.
Promise Bio is a biotechnology research startup transforming immune-mediated disease treatment with advanced precision therapies. Headquartered in Tel Aviv, Israel, the company emerged from stealth following a seed investment.
PAQ Therapeutics is a clinical-stage biotechnology company that utilizes autophagy to develop small-molecule KRAS degraders for the treatment of lethal cancers. The company's research focuses on restoring health and curing diseases that currently lack effective treatment options.
Prazer Therapeutics is a biotechnology company founded in 2019 and headquartered in Seoul, South Korea. The company focuses on developing orally available, brain-penetrating small molecule therapeutics utilizing targeted protein degradation technology for novel drug discovery.
Albatroz Therapeutics is a pre-clinical stage biotechnology company based in Singapore that is developing first-in-class antibody therapeutics to protect the extracellular matrix and treat solid tumors.
Ahammune Biosciences is an India-based drug-discovery biotechnology company focused on developing small-molecule therapies for immune-mediated and inflammatory diseases. It serves pharmaceutical and healthcare markets by advancing novel immunomodulatory drug candidates toward clinical development.
Get Automera's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Automera in Xcout Intel
- 7 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access